Company Information

  

Address: 1 NORTH WAUKEGAN ROAD  
City: NORTH CHICAGO 
State: IL 
Zip Code: 60064 
Telephone: (847) 932-7900 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

AbbVie(1) is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. AbbVie also has a pipeline of promising new medicines, including more than 50 investigational programs in clinical development across such important medical specialties as immunology, virology, oncology and neurology, with additional targeted investment in cystic fibrosis and women's health.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/20175.260.64013.79
03/20175.050.64012.90
12/20164.820.64012.99
09/20163.700.57017.05
06/20163.470.57017.84
03/20163.330.57017.15
12/20153.130.57018.93
09/20151.830.51029.73

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity2.09Total Liab/Total Assets0.93
Net Inc/Total Assets0.09Total Liab/Inv Cap1.10
Net Inc/Inv Cap0.11Total Liab/Comm Equity21.61
Pretax Inc/Net Sales0.31Interest Coverage Ratio9.17
Net Inc/Net Sales0.23Curr Debt/Equity0.09
Cash Flow/Net Sales0.27LTD/Equity7.86
SG&A/NetSales0.23Total Debt/Equity7.95
Asset Utilization   Liquidity  
Net Receivables Turnover5.40Quick Ratio1.51
Inventory Turnover3.69Current Ratio1.65
Inventory Day Sales0.01Net Rec/Curr Assets0.29
Net Sales/Work Cap4.00Inv/Curr Assets0.09
Net Sales/PP&E9.85  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 6,944.00 6,538.00 6,796.00 6,432.00
Cost of Goods Sold 1,528.00 1,616.00 1,555.00 1,504.00
Selling & Admin Exps 1,504.00 1,368.00 1,653.00 1,381.00
Operating Income 2,674.00 2,419.00 2,358.00 2,361.00
Interest Exp 253.00 247.00 290.00 250.00
Pretax Income 2,353.00 2,086.00 1,998.00 2,014.00
Other Income -68.00 -86.00 -70.00 -97.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 1,915.00 1,711.00 1,391.00 1,598.00

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 7,205.00 6,248.00 6,423.00 7,950.00
Receivables - Total 4,859.00 4,677.00 4,758.00 4,999.00
Inventories - Total 1,582.00 1,427.00 1,444.00 1,630.00
Total Current Assets 16,962.00 15,547.00 16,187.00 16,290.00
Net Property, Plant & Equipment 2,657.00 2,612.00 2,604.00 2,638.00
Total Assets 66,994.00 65,664.00 66,099.00 66,626.00
Liabilities        
Accounts Payable 8,839.00 8,419.00 9,379.00 9,077.00
Debt in Current Liabilities 3,420.00 425.00 402.00 26.00
Total Current Liabilities 12,259.00 8,844.00 9,781.00 9,103.00
Long-Term Debt 33,817.00 36,526.00 36,440.00 37,284.00
Total Liabilities 60,985.00 60,666.00 61,463.00 60,157.00
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 18.00 18.00 18.00 18.00
Retained Earnings 5,951.00 5,063.00 4,378.00 4,011.00
Treasury Stock -11,427.00 -11,430.00 -10,852.00 -8,760.00
Total Stockholders' Equity 6,009.00 4,998.00 4,636.00 6,469.00
Total Liabilities and Stockholders' Equity 66,994.00 65,664.00 66,099.00 66,626.00

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities 2,003.00 2,102.00 1,541.00 1,454.00
Net Cash Provided by Investing Activities 318.00 -684.00 -119.00 -199.00
Net Cash Provided by Financing Activities -980.00 -1,794.00 -2,502.00 -1,371.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201218,380.005,275.003.35
12/201318,790.004,128.002.56
12/201419,960.001,774.001.10
12/201522,859.005,144.003.13
12/201625,638.005,953.004.82
Growth Rates8.683.079.52

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1718321,111,12169.70




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.